查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1339319

虚拟临床试验市场、份额、规模、趋势、产业分析报告：按设计、适应症、按阶段、按地区、按细分市场、预测，2023-2032 年

Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球虚拟临床试验市场规模预计将达到285.4408亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

不断增加的研发活动、医疗保健数位化以及远距医疗的采用正在推动虚拟临床试验市场的发展。 这些因素使得临床试验中虚拟测试、远端参与和监控的无缝整合成为可能。 机构间合作和政府支持措施也促进了市场成长。 这些趋势凸显了业界对虚拟方法的关注，这些方法提供灵活性、效率并提高患者对临床试验的参与度。

COVID-19 疫情对临床试验产生了重大影响，导致虚拟试验的采用率增加。 病患招募和保留方面的挑战扰乱了正在进行的临床试验。 虚拟试验已成为疫情期间的一个重要解决方案，它允许参与者在家中参与，并确保研究的连续性，即使无法进行现场访问。

虚拟试验具有许多优势，包括远端收集数据、提高参与者的参与度以及纳入更多的人群。 最大限度地减少与亲自拜访相关的风险，并减轻参与者、协调员和调查员的负担。 透过利用虚拟方法，临床试验产业可以克服挑战、提高效率并促进快速有效的数据收集。

虚拟临床试验市场报告亮点

2022年，由于市场区隔趋势对创新药物的需求以及试验需求的增加，因此干预设计领域主导了市场。

由于癌症发病率上升以及在 COVID-19 大流行期间采用虚拟试验来确保患者安全，预计癌症细分市场将在 2022 年引领市场并保持其主导地位。

由于大型製药公司、政府投资以及Janssen和 PRA Health Sciences 在心臟衰竭患者中进行的分散式卡格列净试验等研究合作，北美在全球虚拟临床试验市场中占据了巨大的收入份额。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第 4 章全球虚拟临床试验市场洞察

  • 虚拟临床试验市场 - 阶段快照
  • 虚拟临床试验市场动态
    • 推动者和机会
      • 技术进步
      • 让研究人员接触到更多样化的全球患者群体
    • 抑制因素和挑战
      • 资料安全与隐私问题
  • PESTEL 分析
  • 虚拟临床试验市场的阶段趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第五章设计的全球虚拟临床试验市场

  • 主要发现
  • 简介
  • 观察测试
  • 干预试验
  • 扩充存取测试

第 6 章全球虚拟临床试验市场（按适应症）

  • 主要发现
  • 简介
  • 中枢神经系统
  • 自体免疫/炎症
  • 循环系统疾病
  • 新陈代谢/内分泌学
  • 传染病
  • 肿瘤学
  • 泌尿系统
  • 眼科

第 7 章全球虚拟临床试验市场（按阶段）

  • 主要发现
  • 简介
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第 8 章全球虚拟临床试验市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年虚拟临床试验市场评估（按地区）
  • 虚拟临床试验市场 - 北美
    • 北美：虚拟临床试验市场（依设计），2019-2032 年
    • 北美：虚拟临床试验市场（按阶段），2019-2032 年
    • 北美：虚拟临床试验市场，依适应症划分，2019-2032 年
    • 虚拟临床试验市场 - 美国
    • 虚拟临床试验市场 - 加拿大
  • 虚拟临床试验市场 - 欧洲
    • 欧洲：虚拟临床试验市场（依设计），2019-2032 年
    • 欧洲：虚拟临床试验市场，依阶段划分，2019-2032 年
    • 欧洲：虚拟临床试验市场（按适应症），2019-2032 年
    • 虚拟临床试验市场 - 英国
    • 虚拟临床试验市场 - 法国
    • 虚拟临床试验市场 - 德国
    • 虚拟临床试验市场 - 义大利
    • 虚拟临床试验市场 - 西班牙
    • 虚拟临床试验市场 - 荷兰
    • 虚拟临床试验市场 - 俄罗斯
  • 虚拟临床试验市场 - 亚太地区
    • 亚太地区：虚拟临床试验市场（依设计），2019-2032 年
    • 亚太地区：虚拟临床试验市场（按阶段），2019-2032 年
    • 亚太地区：虚拟临床试验市场（按适应症），2019-2032 年
    • 虚拟临床试验市场 - 中国
    • 虚拟临床试验市场 - 印度
    • 虚拟临床试验市场 - 马来西亚
    • 虚拟临床试验市场 - 日本
    • 虚拟临床试验市场—印度尼西亚
    • 虚拟临床试验市场—韩国
  • 虚拟临床试验市场 - 中东和非洲
    • 中东与非洲：虚拟临床试验市场（依设计），2019-2032 年
    • 中东与非洲：虚拟临床试验市场（按阶段），2019-2032 年
    • 中东与非洲：虚拟临床试验市场（按适应症），2019-2032 年
    • 虚拟临床试验市场 - 沙乌地阿拉伯
    • 虚拟临床试验市场 - 阿拉伯联合大公国
    • 虚拟临床试验市场 - 以色列
    • 虚拟临床试验市场 - 南非
  • 虚拟临床试验市场 - 拉丁美洲
    • 拉丁美洲：虚拟临床试验市场（依设计），2019-2032 年
    • 拉丁美洲：虚拟临床试验市场，按阶段划分，2019-2032 年
    • 拉丁美洲：虚拟临床试验市场（按适应症），2019-2032 年
    • 虚拟临床试验市场 - 墨西哥
    • 虚拟临床试验市场 - 巴西
    • 虚拟临床试验市场 - 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • LEO Innovation Lab
  • Covance Inc
  • CRF Health
  • Oracle Corporation
  • Medable, Inc
  • Paraxel International
  • Clinical Ink, Inc
  • PRA Health Sciences
  • Science 37
  • ICON plc
Product Code: PM1731

The global virtual clinical trials market size is expected to reach USD 28,544.08 million by 2032, according to a new study by Polaris Market Research. The report "Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased research and development activities, healthcare digitization, and the adoption of telehealth drive the virtual clinical trials market. These factors enable seamless integration of virtual trials, remote participation, and monitoring in clinical studies. Collaborations between organizations and supportive government initiatives contribute to the market's growth. These trends emphasize the industry's focus on virtual methods, which offer flexibility, efficiency, and improved patient engagement in clinical trials.

The COVID-19 pandemic has profoundly impacted clinical trials, leading to increased adoption of virtual trials. Challenges in patient recruitment and retention have been observed, and disruptions to ongoing trials have occurred. Virtual trials emerged as a crucial solution during the pandemic, allowing participants to participate from home and ensuring research continuity when site visits were impossible.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Virtual Clinical Trials Market Report Highlights

The interventional design segment dominated the market in 2022, driven by the need for innovative medications and the increased demand for trials amidst the COVID-19 pandemic.

The oncology segment led the market in 2022 and is expected to maintain its dominance due to the rising incidence of cancer and the adoption of virtual trials for patient safety during the COVID-19 pandemic.

North America holds a significant revenue share in the global virtual clinical trials market, driven by major pharmaceutical companies, government investments, and collaborations like Janssen and PRA Health Sciences' decentralized Canagliflozin study for heart failure patients.

The global key market players include: LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Medable, Inc., Paraxel International, Clinical Ink, Inc., PRA Health Sciences, Science 37, and ICON plc.

Polaris Market Research has segmented the Virtual Clinical Trials market report based on design, indication, phases, and region:

Virtual Clinical Trials, Design Outlook (Revenue - USD Million, 2019 - 2032)

  • Observational Trials
  • Interventional Trials
  • Expanded Access Trials

Virtual Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology

Virtual Clinical Trials, Phases Outlook (Revenue - USD Million, 2019 - 2032)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Virtual Clinical Trials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Virtual Clinical Trials Market Insights

  • 4.1. Virtual Clinical Trials Market - Phases Snapshot
  • 4.2. Virtual Clinical Trials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Technology
      • 4.2.1.2. Researchers to access a more diverse and global patient population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Security and Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Virtual Clinical Trials Market Phases Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Virtual Clinical Trials Market, by Design

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • 5.3. Observational Trials
    • 5.3.1. Global Virtual Clinical Trials Market, by Observational Trials, by Region, 2019-2032 (USD Million)
  • 5.4. Interventional Trials
    • 5.4.1. Global Virtual Clinical Trials Market, by Interventional Trials, by Region, 2019-2032 (USD Million)
  • 5.5. Expanded Access Trials
    • 5.5.1. Global Virtual Clinical Trials Market, by Expanded Access Trials, by Region, 2019-2032 (USD Million)

6. Global Virtual Clinical Trials Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 6.3. CNS
    • 6.3.1. Global Virtual Clinical Trials Market, by CNS, by Region, 2019-2032 (USD Million)
  • 6.4. Autoimmune/Inflammation
    • 6.4.1. Global Virtual Clinical Trials Market, by Autoimmune/Inflammation, by Region, 2019-2032 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Global Virtual Clinical Trials Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
  • 6.6. Metabolic/Endocrinology
    • 6.6.1. Global Virtual Clinical Trials Market, by Metabolic/Endocrinology, by Region, 2019-2032 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Global Virtual Clinical Trials Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
  • 6.8. Oncology
    • 6.8.1. Global Virtual Clinical Trials Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 6.9. Genitourinary
    • 6.9.1. Global Virtual Clinical Trials Market, by Genitourinary, by Region, 2019-2032 (USD Million)
  • 6.10. Ophthalmology
    • 6.10.1. Global Virtual Clinical Trials Market, by Ophthalmology, by Region, 2019-2032 (USD Million)

7. Global Virtual Clinical Trials Market, by Phases

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • 7.3. Phase I
    • 7.3.1. Global Virtual Clinical Trials Market, by Phase I, By Region, 2019-2032 (USD Million)
  • 7.4. Phase II
    • 7.4.1. Global Virtual Clinical Trials Market, by Phase II, By Region, 2019-2032 (USD Million)
  • 7.5. Phase III
    • 7.5.1. Global Virtual Clinical Trials Market, by Phase III, By Region, 2019-2032 (USD Million)
  • 7.6. Phase IV
    • 7.6.1. Global Virtual Clinical Trials Market, by Phase IV, By Region, 2019-2032 (USD Million)

8. Global Virtual Clinical Trials Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Virtual Clinical Trials Market - North America
    • 8.3.1. North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.3.2. North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.3.3. North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.3.4. Virtual Clinical Trials Market - U.S.
      • 8.3.4.1. U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.3.5. Virtual Clinical Trials Market - Canada
      • 8.3.5.1. Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.4. Virtual Clinical Trials Market - Europe
    • 8.4.1. Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.4.3. Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.4. Virtual Clinical Trials Market - UK
      • 8.4.4.1. UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.5. Virtual Clinical Trials Market - France
      • 8.4.5.1. France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.5.3. France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.6. Virtual Clinical Trials Market - Germany
      • 8.4.6.1. Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.7. Virtual Clinical Trials Market - Italy
      • 8.4.7.1. Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.8. Virtual Clinical Trials Market - Spain
      • 8.4.8.1. Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.9. Virtual Clinical Trials Market - Netherlands
      • 8.4.9.1. Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.10. Virtual Clinical Trials Market - Russia
      • 8.4.10.1. Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.5. Virtual Clinical Trials Market - Asia Pacific
    • 8.5.1. Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.4. Virtual Clinical Trials Market - China
      • 8.5.4.1. China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.4.3. China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.5. Virtual Clinical Trials Market - India
      • 8.5.5.1. India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.5.3. India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.6. Virtual Clinical Trials Market - Malaysia
      • 8.5.6.1. Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.7. Virtual Clinical Trials Market - Japan
      • 8.5.7.1. Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.8. Virtual Clinical Trials Market - Indonesia
      • 8.5.8.1. Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.9. Virtual Clinical Trials Market - South Korea
      • 8.5.9.1. South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.6. Virtual Clinical Trials Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.4. Virtual Clinical Trials Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.5. Virtual Clinical Trials Market - UAE
      • 8.6.5.1. UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.6. Virtual Clinical Trials Market - Israel
      • 8.6.6.1. Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.7. Virtual Clinical Trials Market - South Africa
      • 8.6.7.1. South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.7. Virtual Clinical Trials Market - Latin America
    • 8.7.1. Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.4. Virtual Clinical Trials Market - Mexico
      • 8.7.4.1. Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.5. Virtual Clinical Trials Market - Brazil
      • 8.7.5.1. Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.6. Virtual Clinical Trials Market - Argentina
      • 8.7.6.1. Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. LEO Innovation Lab
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Covance Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CRF Health
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Oracle Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Medable, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Paraxel International
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Clinical Ink, Inc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. PRA Health Sciences
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Science 37
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ICON plc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 2 Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 3 Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 4 Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 6 North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 7 North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 8 U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 9 U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 10 U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 11 Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 12 Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 13 Canada: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 14 Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 15 Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 16 Europe: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 17 UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 18 UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 19 UK: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 20 France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 21 France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 22 France: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 23 Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 24 Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 25 Germany: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 26 Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 27 Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 28 Italy: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 29 Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 30 Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 31 Spain: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 32 Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 33 Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 34 Netherlands: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 35 Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 36 Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 37 Russia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 41 China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 42 China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 43 China: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 44 India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 45 India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 46 India: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 47 Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 48 Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 49 Malaysia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 50 Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 51 Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 52 Japan: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 53 Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 54 Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 55 Indonesia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 56 South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 57 South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 58 South Korea: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 65 UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 66 UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 67 UAE: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 68 Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 69 Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 70 Israel: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 71 South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 72 South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 73 South Africa: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 74 Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 75 Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 76 Latin America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 77 Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 78 Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 79 Mexico: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 80 Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 81 Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 82 Brazil: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 83 Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 84 Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 85 Argentina: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Virtual Clinical Trials Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Indication
  • Figure 7. Global Virtual Clinical Trials Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 8. Market by Design
  • Figure 9. Global Virtual Clinical Trials Market, by Design, 2022 & 2032 (USD Million)
  • Figure 10. Market by Phases
  • Figure 11. Global Virtual Clinical Trials Market, by Phases, 2022 & 2032 (USD Million)
  • Figure 12. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Virtual Clinical Trials Market